British Columbia Investment Management’s Tandem Diabetes Care TNDM Stock Holding History

British Columbia Investment Management’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-90,000	Closed	-$5.33M	–	828
2022 Q2	$5.33M	Hold	90,000	–	–	0.05%	284
2022 Q1	$10.5M	Buy	90,000 +13,200	+17%	+$1.54M	0.07%	241
2021 Q4	$11.6M	Sell	76,800 -23,200	-23%	-$3.13M	0.07%	257
2021 Q3	$11.9M	Sell	100,000 -25,920	-21%	-$2.86M	0.07%	244
2021 Q2	$12.3M	Hold	125,920	–	–	0.08%	245
2021 Q1	$11.1M	Sell	125,920 -2,500	-2%	-$232K	0.08%	229
2020 Q4	$12.3M	Buy	128,420 +31,000	+32%	+$3.19M	0.09%	209
2020 Q3	$11.1M	Buy	+97,420	New	+$10.2M	0.09%	196

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

British Columbia Investment Management's TNDM Position: Q3 2022 in Review

British Columbia Investment Management sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 90,000 shares — an estimated $5.33M sold.

British Columbia Investment Management first reported a position in TNDM in Q3 2020 and held it in 8 quarters. The position peaked at $12.3M in Q4 2020. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

British Columbia Investment Management reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
British Columbia Investment Management sold 90,000 Tandem Diabetes Care shares in Q3 2022, an estimated $5.33M.
British Columbia Investment Management first reported a position in Tandem Diabetes Care in Q3 2020 and held it in 8 quarters.
British Columbia Investment Management's Tandem Diabetes Care position peaked at $12.3M in Q4 2020.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on British Columbia Investment Management's 13F filing for Q3 2022, filed 10 Nov 2022.